Bian Y - Search Results

1

Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.

Bian Y, Li W, Kremer DM, Sajjakulnukit P, Li S, Crespo J, Nwosu ZC, Zhang L, Czerwonka A, Pawłowska A, Xia H, Li J, Liao P, Yu J, Vatan L, Szeliga W, Wei S, Grove S, Liu JR, McLean K, Cieslik M, Chinnaiyan AM, Zgodziński W, Wallner G, Wertel I, Okła K, Kryczek I, Lyssiotis CA, Zou W. Bian Y, et al. Nature. 2020 Sep;585(7824):277-282. doi: 10.1038/s41586-020-2682-1. Epub 2020 Sep 2. Nature. 2020. PMID: 32879489 Free PMC article.

2

Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.

Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, Rizvi SM, Qin A, Waninger JJ, Lang X, Chopra Z, El Naqa I, Zhou J, Bian Y, Jiang L, Tezel A, Skvarce J, Achar RK, Sitto M, Rosen BS, Su F, Narayanan SP, Cao X, Wei S, Szeliga W, Vatan L, Mayo C, Morgan MA, Schonewolf CA, Cuneo K, Kryczek I, Ma VT, Lao CD, Lawrence TS, Ramnath N, Wen F, Chinnaiyan AM, Cieslik M, Alva A, Zou W. Yu J, et al. Among authors: bian y. Nat Med. 2021 Jan;27(1):152-164. doi: 10.1038/s41591-020-1131-x. Epub 2021 Jan 4. Nat Med. 2021. PMID: 33398162 Free PMC article.

3

Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis.

Xia H, Li S, Li X, Wang W, Bian Y, Wei S, Grove S, Wang W, Vatan L, Liu JR, McLean K, Rattan R, Munkarah A, Guan JL, Kryczek I, Zou W. Xia H, et al. Among authors: bian y. JCI Insight. 2020 Sep 17;5(18):e141115. doi: 10.1172/jci.insight.141115. JCI Insight. 2020. PMID: 32780724 Free PMC article.

4

Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance.

Lin H, Kryczek I, Li S, Green MD, Ali A, Hamasha R, Wei S, Vatan L, Szeliga W, Grove S, Li X, Li J, Wang W, Yan Y, Choi JE, Li G, Bian Y, Xu Y, Zhou J, Yu J, Xia H, Wang W, Alva A, Chinnaiyan AM, Cieslik M, Zou W. Lin H, et al. Among authors: bian y. Cancer Cell. 2021 Apr 12;39(4):480-493.e6. doi: 10.1016/j.ccell.2020.12.023. Epub 2021 Jan 28. Cancer Cell. 2021. PMID: 33513345 Free PMC article.

5

CD8⁺ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4.

Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, Kennedy PD, Gijón M, Shah YM, Zou W. Liao P, et al. Among authors: bian y. Cancer Cell. 2022 Apr 11;40(4):365-378.e6. doi: 10.1016/j.ccell.2022.02.003. Epub 2022 Feb 24. Cancer Cell. 2022. PMID: 35216678 Free PMC article.

6

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: bian y. Nat Commun. 2019 Aug 28;10(1):3874. doi: 10.1038/s41467-019-11782-w. Nat Commun. 2019. PMID: 31462678 Free PMC article.

7

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX. Liang Y, et al. Among authors: bian y. Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y. Nat Commun. 2018. PMID: 30389912 Free PMC article.

8

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: bian y. Nat Commun. 2020 Apr 1;11(1):1716. doi: 10.1038/s41467-020-15532-1. Nat Commun. 2020. PMID: 32238807 Free PMC article.

9

Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B.

Wang W, Zhou X, Bian Y, Wang S, Chai Q, Guo Z, Wang Z, Zhu P, Peng H, Yan X, Li W, Fu YX, Zhu M. Wang W, et al. Among authors: bian y. Nat Nanotechnol. 2020 May;15(5):406-416. doi: 10.1038/s41565-020-0648-y. Epub 2020 Mar 2. Nat Nanotechnol. 2020. PMID: 32123380 Free PMC article.

10

Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination.

Zhu D, Liu L, Yang D, Fu S, Bian Y, Sun Z, He J, Su L, Zhang L, Peng H, Fu YX. Zhu D, et al. Among authors: bian y. J Immunol. 2016 Apr 1;196(7):3079-87. doi: 10.4049/jimmunol.1502061. Epub 2016 Mar 2. J Immunol. 2016. PMID: 26936879 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,267 results

Search Page